[HTML][HTML] Overview of complement activation and regulation

M Noris, G Remuzzi - Seminars in nephrology, 2013 - Elsevier
Complement is an important component of the innate immune system that is crucial for
defense from microbial infections and for clearance of immune complexes and injured cells …

STEC-HUS, atypical HUS and TTP are all diseases of complement activation

M Noris, F Mescia, G Remuzzi - Nature Reviews Nephrology, 2012 - nature.com
Haemolytic uraemic syndrome (HUS) and thrombotic thrombocytopaenic purpura (TTP) are
diseases characterized by microvascular thrombosis, with consequent thrombocytopaenia …

Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement

P Avirutnan, N Punyadee, S Noisakran… - The Journal of …, 2006 - academic.oup.com
Background Vascular leakage and shock are the major causes of death in patients with
dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Thirty years ago …

Inhibiting the C5–C5a receptor axis

TM Woodruff, KS Nandakumar, F Tedesco - Molecular immunology, 2011 - Elsevier
Activation of the complement system is a major pathogenic event that drives various
inflammatory responses in numerous diseases. All pathways of complement activation lead …

Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor

F Fischetti, P Durigutto, V Pellis, A Debeus, P Macor… - Blood, 2005 - ashpublications.org
We monitored the number of intravascular platelet-leukocyte aggregates (PLAs) and
thrombotic occlusions (TOs) by intravascular microscopy in the mesentery of rats receiving …

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas

O Manches, G Lui, L Chaperot… - Blood, The Journal …, 2003 - ashpublications.org
To assess the sensitivity of primary non-Hodgkin lymphoma cells to rituximab-mediated
cytotoxicity, we compared the potency of several rituximab-mediated killing mechanisms on …

Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity

T van Meerten, RS van Rijn, S Hol, A Hagenbeek… - Clinical cancer …, 2006 - AACR
Purpose: The use of the CD20-specific antibody rituximab has greatly improved the
response to treatment of CD20+ follicular lymphoma. Despite the success of rituximab …

The complement alternative pathway and hemostasis

M Noris, M Galbusera - Immunological Reviews, 2023 - Wiley Online Library
The complement and hemostatic systems are complex systems, and both involve enzymatic
cascades, regulators, and cell components—platelets, endothelial cells, and immune cells …

Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation

L Deban, H Jarva, MJ Lehtinen, B Bottazzi… - The Journal of …, 2008 - journals.aai.org
The long pentraxin PTX3 is a multifunctional soluble molecule involved in inflammation and
innate immunity. As an acute phase protein, PTX3 binds to the classical pathway …

The complement system in the pathophysiology of pregnancy and in systemic autoimmune rheumatic diseases during pregnancy

CB Chighizola, PA Lonati, L Trespidi… - Frontiers in …, 2020 - frontiersin.org
The complement system plays a double role in pregnancy exerting both protective and
damaging effects at placental level. Complement activation at fetal-maternal interface …